The Chinese-language United Daily News (UDN) yesterday reported that an FDA expert panel remained largely unchanged from last year to May 6. The KMT caucus has requested transparency in the EUA process to ensure that it is not treated as a mere formality, he said. The meetings on May 6 and May 28 were convened to discuss methods of evaluating vaccine efficacy and whether immunobridging could be used in the EUA process, it said. The second meeting was called to discuss EUA standards in detail, so the scientists involved in clinical trials were not invited, it said, adding that statisticians were sought, as the topic required their expertise. Such meetings inform the agency’s decisions, but are distinct from those held to decide EUA standards, so it was willful misrepresentation by the media, the FDA said.

Source: Taipei Times June 24, 2021 15:56 UTC